Histochemical evaluation of placental dipeptidyl peptidase IV (CD26) in pre-eclampsia: Enzyme activity in villous trophoblast indicates an enhanced likelihood of gestational hypertensive disorders

American Journal of Reproductive Immunology

Volumn 37, Issue 6, 1997, Pages 449-458

  Neudeck, Hermann ^a   Joncic, Marion ^a   Schuster, Christof ^a   Bisson, Susanne ^a   Hildebrandt, Ruth ^a   Öney, Taylan ^a   Stiemer, Beate ^a   Hopp, Hartmut ^a   Graf, Renate ^a  

^a NONE

Author keywords

CD26; Dipeptidyl peptidase IV; DPP IV; Human placenta; Pre eclampsia

Indexed keywords

DIPEPTIDYL PEPTIDASE IV; PLACENTA ENZYME;

CHORION VILLUS; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME HISTOCHEMISTRY; ENZYME KINETICS; ENZYME SUBSTRATE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MICROSCOPY; PLACENTA; PREECLAMPSIA; PRIORITY JOURNAL; RISK; TROPHOBLAST;

EID: 0030958899     PISSN: 87558920     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0897.1997.tb00259.x     Document Type: Conference Paper

References (34)

1. Reutter W, Baum O, Löster K, Fan H, Bork JP, Bernt K, Hanski C, Tauber R: Functional aspects of the three extracellular domains of dipeptidyl peptidase IV: Characterization of glycosylation events, of the collagen-binding site and of endopeptidase activity. In Dipeptidyl Peptidase IV (CD26) in Metabolism and the Immune Response, B Fleischer (ed), New York, Berlin, Springer, 1995, pp 55-78.
2. Darmoul D, Lacasa M, Baricault L, Marguet D, Sapin C, Trotot P, Barbat A, Trugnan G: Dipeptidyl peptidase IV (CD26) gene expression in enterocyte-like colon cancer cell lines HAT-29 and Caco-2. Cloning of the complete human coding sequence and changes of dipeptidyl peptidase IV mRNA levels during cell differentiation. J Biol Chem 1992; 267:4824-4833.
3. Piazza GA, Callanan HM, Mowery J, Hixson DC: Evidence for a role of dipeptidyl peptidase IV in fibronectin-mediated interactions of hepatocytes with extracellular matrix. Brachem J 1989; 262:327-334.
4. Munoz E, Blazquez MV, Madueno JA, Rubio G, Pena J: CD26 induces T cell proliferation by tyrosin protein phosphorylation. Immunology 1992; 77:43-50.
5. Kubota T, Flentke GR, Bachovchin WW, Stollar BD: Involvement of dipeptidyl peptidase IV in an in vivo immune response. Clin Exp Immunol 1992; 89:192-197.
6. Hopsu-Havu VK, Glenner GO: A new dipeptide naphthylamidase hydrolyzing glycyl-prolyl-β-naphthylamide, Histochemie 1966; 7:197-200.
7. Couture R, Regoli D: Mini review: Smooth muscle pharmacology of substance P. Pharmacology 1982; 24:1-25.
8. Mentlein R: Proline residues in the maturation and degradation of peptide hormones and neuropeptides. FEBS Lett 1988; 234:251-256.
9. Püschel G, Mentlein R, Heymann E: Isolation and characterization of dipeptidyl peptidase IV from human placenta. Eur J Biochem 1982; 126:359-365.
10. Mizutani S, Sumi S, Narita O, Tomoda Y: Purification and properties of human placental dipeptidyl peptidase IV. Acta Obstet Gynaecol Jpn 1985; 37:769-775.
11. Gossrau R, Graf R, Ruhnke M, Hanski C: Proteases in the human full-term placenta. Histochemistry 1987; 86:405-413.
12. Heymann E, Mentlein R: Is dipeptidyl peptidase IV involved in the regulation of blood pressure and coagulation? (Beeinflussst Dipeptidylpeptidase IV Blutdruck und Gerinnung?), Klin Wochenschr 1984; 62:2-10.
13. Symonds EM: The placenta and the renin-angiotensin system. J Reprod Med 1979; 23:129-133.
14. Cunningham FG, MacDonald PC, Grant NF, Leveno KJ, Gilstrap III LC: Williams Obstetrics. Norwalk, CT, Appleton & Lange, 1993, pp 763-817.
15. Hughes EC: Hypertensive states of pregnancy. Classification. In Obstetric-Gynecologic Terminology, EC Hughes (ed). Philadelphia, Davis, 1972, pp 422-423.
16. Nicki R: Entwicklung von Gewicht, Länge, Gewicht-Längenquotient und Kopfumfang in Abhängigkeit von der Schwangerschaftsdauer, Münchner Mittelwertkurven. München, Inaug Diss, 1972.
17. Benirschke K: Examination of the placenta. Obstet Gynecol 1961; 18:309-333.
18. Lojda Z, Gossrau R, Stoward PJ: Proteases. Histochemical methods for proteases. In Histochemistry, Theoretical and Applied. Vol 3: Enzyme Histochemistry, PJ Stoward, AGE Pearse (eds). Edinburgh, Churchill Livingstone, 1991, pp 281-335, 639-652.
19. Remmele W, Stegner HE: Vorschlag zur einheitlichen Definition eines Immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptor-Nachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 1987; 8:138-140.
20. Dixon W, Webb EC: Enzymes. London, Longman Group Ltd, 1979, pp 126-137.
21. Agresti A: Categorical Data Analysis. New York, John Wiley & Sons, 1990.
22. McCullagh P, Nelder JA: Generalized Linear Models. London, Chapman and Hall, 1989, pp 149-155.
23. Myatt L: Current topic: Control of vascular resistance in the human placenta. Placenta 1992; 13:329-341.
24. Neudeck H, Schuster C, Hildebrandt R, Öney T, Stiemer B, Hopp H, Graf R: Histochemical evaluation of placental angiotensinase A in pre-eclampsia: Enzyme activity in villous trophoblast indicates an enhanced likelihood of gestational proteinuric hypertension. Placenta 1996; 17:155-163.
25. Wang L, Ahmad S, Benter IF, Chow A, Mizutani S, Ward PE: Differential processing of substance P and neurokinin A by plasma dipeptidyl(amino)peptidase IV, aminopeptidase M and angiotensin converting enzyme. Peptides 1991; 12:1357-1364.
26. Ahmad S, Wang L, Ward PE: Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P. J Pharmacol Exp Ther 1992; 260:1257-1261.
27. Kanfer A, Bruch J-F, Nguyen G, He CJ, Delarue F, Flahault A, Nessmann C, Uzan S: Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia. Lab Invest 1996; 74:253-258.
28. Neudeck H, Joncic M, Gutsmann M, Hopp H, Graf R: Dipeptidyl peptidase IV is associated with perivillous matrix-type fibrinoid in human placental infarcts. Placenta 17:A35.
29. Stein H, Schwarting R, Niedobitek G: Cluster report CD26. In Leukocyte Typing IV, W Knapp, B Dorken, WR Gilks (eds). Oxford, UK, Oxford, 1989, pp 412-418.
30. Ansorge S, Bühling F, Hoffmann T, Kähne T, Neubert K, Reinhold D: DP IV/CD26 on human lymphocytes: Functional roles in cell growth and cytokine regulation. In Dipeptidyl Peptidase IV (CD26) in Metabolism and the Immune Response. B Fleischer (ed), New York, Berlin. Springer, 1995, pp 163-184.
31. Morimoto C, Schlossman SF: CD26: A key costimulatory molecule involved in CD4 memory T cell function and activation. In Dipeptidyl Peptidase IV (CD26) in Metabolism and the Immune Response, B Fleischer (ed), New York, Berlin, Springer, 1995, pp 131-143.
32. Reinhold D, Bank U, Bühling F, Neubert K, Mattern T, Ulmer AJ, Flad HD, Ansorge S: Dipeplidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimuluted peripheral blood mononuclear cells, and IL-2 and IL-6 production. Immunobiology 1993; 188:403-414.
33. Kupferminc MJ, Peaceman AM, Aderka D, Wallach D, Socol ML: Soluble tumor necrosis factor receptors and interleukin-6 levels in patients with severe preeclampsia. Obstet Gynecol 1996; 88:420-427.
34. Lyall F, Greer IA, Boswell F, Young A: Interleukin-6 stimulates E-selectin and VCAM-1 expression in endothelial cells in vitro: A role in pre-eclampsia? In International Society for the Study of Hypertension in Pregnancy (ISSHP), Leuven, Belgium, 1995, p 4.